OR WAIT null SECS
February 02, 2020
Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.
October 02, 2019
Establishing OEL data and ensuring appropriate engineering controls are crucial aspects of safe handling.
August 02, 2019
The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise.
July 10, 2019
The expansion of Lonza’s Tampa site includes development and manufacturing capabilities for oral solid-dose drugs.
April 24, 2019
Expansion at the Eberbach, Germany facility includes two Vegicap encapsulation lines, printing, inspection, and packaging capabilities.
March 20, 2019
Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.
January 03, 2019
The $252-million acquisition is expected to strengthen Cambrex’s position as a small-molecule CDMO across the drug lifecycle.
November 05, 2018
Bioprocessing and manufacturing events bioLIVE and BioProduction Congress will take place as one event adjacent to CPhI Worldwide in Frankfurt, Germany, on November 5–7, 2019.
July 23, 2018
The acquisition will place Cambrex into the finished dosage form CDMO market.
May 16, 2018
As more continuous processes move toward commercialization, users and equipment vendors are working to speed changeovers and address other needs.